4.6 (594) In stock
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 - ScienceDirect
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study - Biology
Acute Lymphoblastic Leukemia in Children (05.10.2012)
Frontiers Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
Treatment of Childhood Acute Lymphoblastic Leukemia - ScienceDirect
Nuclear power in France - Wikipedia
Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia
Lutz LÖNING, Klinikum Oldenburg, Oldenburg
Figure 1 from Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Frontiers Model-Based Simulation of Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia
Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group
JKMS :: Journal of Korean Medical Science
Richard RATEI, Head of Department
Richard RATEI, Head of Department
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
